Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

AstraZeneca boss Pascal Soriot dismisses exit talk

AstraZeneca PLC (LSE:AZN) boss Pascal Soriot has told Bloomberg that reports of his imminent departure from the drugmaker are “fake news.”

Soriot, speaking at the European Society for Medical Oncology in Madrid, said: "I read these rumors and I can tell you - there’s nothing further from the truth. This is totally made up. Absolutely made up.”

There were reports earlier this month that AstraZeneca Chairman Michel Demare had started to look for a replacement for Soriot, who has been at the helm since October 2012.

Since he took over, shares in the drugmaker have jumped by just over 250%.

The Frenchman, who has been in the role since 2012, was reported to have told friends that he was considering leaving "as soon as next year", according to the Daily Mail.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK